FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1758-1759 June 16, 1994 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cooper, D. A. PubMed Citation

To the Editor: The report of the randomized trial by the European-Australian Collaborative Group of zidovudine in asymptomatic HIV infection (July 29 issue)¹ contains a serious statistical error. Berger has already pointed out (Dec. 16 issue)² that changes in CD4+ cell counts are of questionable clinical importance and should not have been combined with AIDS and AIDS-related complex in the analysis of disease progression. Far more serious, however, was the failure to analyze the results according to random assignment with complete follow-up. Patients' data were censored three months after treatment stopped, leading to 173 withdrawals in the zidovudine group and . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.